# Inference of Genetic Networks from Pseudo Time Series of Single-cell Gene Expression Data using Modified Random Forests

**Authors:** Shuhei Kimura, Ryosuke Misaki, Masato Tokuhisa, Keita Iida, Mariko Okada

PMC · DOI: 10.1007/s11538-026-01612-8 · 2026-02-21

## TL;DR

This paper introduces a new method to infer genetic networks from single-cell gene expression data without needing precise time information.

## Contribution

The novel approach uses signs of gene expression changes instead of time derivatives for pseudo time-series data.

## Key findings

- The method was validated using both artificial and real gene expression data.
- It performs well in inferring genetic networks from pseudo time-series data.
- The approach is based on and extends the GENIE3 framework.

## Abstract

This study proposes a novel method for inferring genetic networks using both steady-state and pseudo time-series data of single-cell gene expressions. While several methods for inferring genetic networks from time series of bulk-cell gene expression data have been proposed, many of these approaches use time derivatives of gene expression levels. However, since pseudo time-series data lack precise temporal information about when measurements were taken, time derivatives cannot be calculated from this data. Therefore, existing methods are ineffective for analyzing pseudo time-series data. To address this limitation, our proposed method does not use time derivatives of gene expression levels but uses their signs. We theorize that, even when no precise temporal information is available, the signs of time derivatives, which indicate whether the gene expression levels are increasing or decreasing, can be estimated from pseudo time-series data. Our approach was designed on the basis of GENIE3 and its extensions, which, although essentially intended to infer genetic networks from bulk-cell gene expression data, have reportedly performed well in this respect. Validation through numerical experiments with both artificial and real gene expression data confirms the effectiveness of our proposed method.

The online version contains supplementary material available at 10.1007/s11538-026-01612-8.

## Full-text entities

- **Genes:** EFNA1 (ephrin A1) [NCBI Gene 1942] {aka B61, ECKLG, EPLG1, GMAN, LERK-1, LERK1}, RBM5 (RNA binding motif protein 5) [NCBI Gene 10181] {aka G15, H37, LUCA-15, LUCA15, RMB5}, CDC42 (cell division cycle 42) [NCBI Gene 998] {aka CDC42Hs, G25K, TKS}, CWC25 (CWC25 spliceosome associated protein) [NCBI Gene 54883] {aka CCDC49}, ZNF326 (zinc finger protein 326) [NCBI Gene 284695] {aka ZAN75, ZIRD, Zfp326, dJ871E2.1}, FIP1L1 (factor interacting with PAPOLA and CPSF1) [NCBI Gene 81608] {aka FIP1, Rhe, hFip1}, NRAS (NRAS proto-oncogene, GTPase) [NCBI Gene 4893] {aka ALPS4, CMNS, N-ras, NCMS, NRAS1, NS6}, SNRNP27 (small nuclear ribonucleoprotein U4/U6.U5 subunit 27) [NCBI Gene 11017] {aka 27K, RY1}, SART3 (spliceosome associated factor 3, U4/U6 recycling protein) [NCBI Gene 9733] {aka DSAP1, P100, RP11-13G14, TIP110, p110, p110(nrb)}, THRAP3 (thyroid hormone receptor associated protein 3) [NCBI Gene 9967] {aka BCLAF2, TRAP150}, GRB2 (growth factor receptor bound protein 2) [NCBI Gene 2885] {aka ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2}, STMN1 (stathmin 1) [NCBI Gene 3925] {aka C1orf215, LAP18, Lag, OP18, PP17, PP19}, NCBP2 (nuclear cap binding protein subunit 2) [NCBI Gene 22916] {aka CBC2, CBP20, NIP1, PIG55}, HSPB1 (heat shock protein family B (small) member 1) [NCBI Gene 3315] {aka CMT2F, HEL-S-102, HMN2B, HMND3, HS.76067, HSP27}, RAC1 (Rac family small GTPase 1) [NCBI Gene 5879] {aka MIG5, MRD48, Rac-1, TC-25, p21-Rac1}, ERBB3 (erb-b2 receptor tyrosine kinase 3) [NCBI Gene 2065] {aka ErbB-3, FERLK, HER3, LCCS2, MDA-BF-1, VSCN1}, FOS (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 2353] {aka AP-1, C-FOS, p55}, PQBP1 (polyglutamine binding protein 1) [NCBI Gene 10084] {aka MRX2, MRX55, MRXS3, MRXS8, NPW38, RENS1}, SFSWAP (splicing factor SWAP) [NCBI Gene 6433] {aka SFRS8, SWAP}, LSM8 (LSM8 homolog, U6 small nuclear RNA associated) [NCBI Gene 51691], ZNF638 (zinc finger protein 638) [NCBI Gene 27332] {aka NP220, ZFML, Zfp638}, F3 (coagulation factor III, tissue factor) [NCBI Gene 2152] {aka CD142, TF, TFA}, HSPA1A (heat shock protein family A (Hsp70) member 1A) [NCBI Gene 3303] {aka HEL-S-103, HSP70, HSP70-1, HSP70-1A, HSP70-2, HSP70.1}, FAM50A (family with sequence similarity 50 member A) [NCBI Gene 9130] {aka 9F, DXS9928E, HXC-26, HXC26, MRXSA, XAP5}, AKAP17A (A-kinase anchoring protein 17A) [NCBI Gene 8227] {aka 721P, AKAP-17A, CCDC133, CXYorf3, DXYS155E, PRKA17A}, HSPA8 (heat shock protein family A (Hsp70) member 8) [NCBI Gene 3312] {aka HEL-33, HEL-S-72p, HSC54, HSC70, HSC71, HSP71}, LSM10 (LSM10, U7 small nuclear RNA associated) [NCBI Gene 84967] {aka MST074, MSTP074}, SART1 (spliceosome associated factor 1, recruiter of U4/U6.U5 tri-snRNP) [NCBI Gene 9092] {aka Ara1, HAF, HOMS1, SART1259, SNRNP110, Snu66}
- **Diseases:** breast cancer (MESH:D001943), oral squamous cell carcinoma (MESH:D000077195), GSD (MESH:D016098)
- **Chemicals:** tamoxifen (MESH:D013629)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031)

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12923446/full.md

---
Source: https://tomesphere.com/paper/PMC12923446